<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vaccine Design - Comprehensive Guide</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        
        .main-slide {
            width: 100%;
            padding: 40px 60px;
            background: white;
        }
        
        .title {
            font-size: 36px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
            padding-bottom: 15px;
            border-bottom: 3px solid #1E64C8;
        }
        
        .content-wrapper {
            display: flex;
            gap: 25px;
            min-height: 385px;
        }
        
        .vaccine-visual {
            flex: 1.4;
            display: flex;
            align-items: center;
            justify-content: center;
        }
        
        .design-principles {
            flex: 1;
            display: flex;
            flex-direction: column;
            gap: 14px;
        }
        
        .principle-item {
            background: #f8f9fa;
            border-left: 4px solid #1E64C8;
            border-radius: 6px;
            padding: 13px 18px;
            transition: all 0.3s ease;
        }
        
        .principle-item:hover {
            background: #e8f2ff;
            transform: translateX(8px);
        }
        
        .principle-name {
            font-size: 16px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 3px;
        }
        
        .principle-detail {
            font-size: 12px;
            color: #666;
        }
        
        /* Detailed Sections */
        .detailed-section {
            padding: 50px 60px;
            border-top: 2px solid #e0e0e0;
            background: white;
        }
        
        .detailed-section:nth-child(even) {
            background: #fafbfc;
        }
        
        .section-title {
            font-size: 28px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 25px;
            padding-bottom: 10px;
            border-bottom: 2px solid #1E64C8;
        }
        
        .section-content {
            display: flex;
            gap: 40px;
            align-items: flex-start;
        }
        
        .section-visual {
            flex: 1;
            display: flex;
            justify-content: center;
            align-items: center;
        }
        
        .section-text {
            flex: 1;
        }
        
        .section-text h3 {
            font-size: 20px;
            color: #2c3e50;
            margin-bottom: 15px;
            margin-top: 20px;
        }
        
        .section-text h3:first-child {
            margin-top: 0;
        }
        
        .section-text p {
            font-size: 15px;
            line-height: 1.7;
            color: #555;
            margin-bottom: 12px;
        }
        
        .section-text ul {
            margin-left: 20px;
            margin-bottom: 15px;
        }
        
        .section-text li {
            font-size: 15px;
            line-height: 1.7;
            color: #555;
            margin-bottom: 8px;
        }
        
        .highlight-box {
            background: #e8f2ff;
            border-left: 4px solid #1E64C8;
            padding: 15px 20px;
            margin: 20px 0;
            border-radius: 4px;
        }
        
        .highlight-box strong {
            color: #1E64C8;
        }
        
        .rna-wave {
            animation: rnaWave 3s ease-in-out infinite;
        }
        
        @keyframes rnaWave {
            0%, 100% { d: path("M 0,0 Q 10,10 20,0 T 40,0 T 60,0 T 80,0"); }
            50% { d: path("M 0,0 Q 10,-10 20,0 T 40,0 T 60,0 T 80,0"); }
        }
        
        .immune-pulse {
            animation: immunePulse 2s ease-in-out infinite;
        }
        
        @keyframes immunePulse {
            0%, 100% { r: 15; opacity: 0.6; }
            50% { r: 20; opacity: 1; }
        }
        
        .binding-animation {
            animation: binding 2s ease-in-out infinite;
        }
        
        @keyframes binding {
            0%, 100% { transform: translateX(0); }
            50% { transform: translateX(-5px); }
        }
    </style>
</head>
<body>
    <div class="container">
        <!-- Original Main Slide -->
        <div class="main-slide">
            <div class="title">Vaccine Design</div>
            <div class="content-wrapper">
                <div class="vaccine-visual">
                    <svg width="520" height="385" viewBox="0 0 520 385">
                        <text x="260" y="20" font-size="15" fill="#333" text-anchor="middle" font-weight="600">AI-Driven Vaccine Development</text>
                        
                        <!-- Pathogen -->
                        <g transform="translate(60, 60)">
                            <text x="0" y="-10" font-size="12" fill="#666" font-weight="600">Pathogen</text>
                            
                            <!-- Virus particle -->
                            <circle cx="30" cy="30" r="25" fill="#ffcccc" stroke="#cc0000" stroke-width="2"/>
                            
                            <!-- Spike proteins -->
                            <g transform="translate(30, 30)">
                                <line x1="0" y1="-25" x2="0" y2="-35" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="0" cy="-38" r="3" fill="#cc0000"/>
                                
                                <line x1="18" y1="-18" x2="25" y2="-25" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="27" cy="-27" r="3" fill="#cc0000"/>
                                
                                <line x1="25" y1="0" x2="35" y2="0" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="38" cy="0" r="3" fill="#cc0000"/>
                                
                                <line x1="18" y1="18" x2="25" y2="25" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="27" cy="27" r="3" fill="#cc0000"/>
                                
                                <line x1="0" y1="25" x2="0" y2="35" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="0" cy="38" r="3" fill="#cc0000"/>
                                
                                <line x1="-18" y1="18" x2="-25" y2="25" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="-27" cy="27" r="3" fill="#cc0000"/>
                                
                                <line x1="-25" y1="0" x2="-35" y2="0" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="-38" cy="0" r="3" fill="#cc0000"/>
                                
                                <line x1="-18" y1="-18" x2="-25" y2="-25" stroke="#cc0000" stroke-width="2"/>
                                <circle cx="-27" cy="-27" r="3" fill="#cc0000"/>
                            </g>
                            
                            <text x="30" y="30" font-size="10" fill="#333" text-anchor="middle" font-weight="600">SARS-CoV-2</text>
                        </g>
                        
                        <!-- Epitope Prediction -->
                        <defs>
                            <marker id="vaccArrow" markerWidth="8" markerHeight="8" refX="7" refY="3" orient="auto">
                                <polygon points="0 0, 8 3, 0 6" fill="#1E64C8"/>
                            </marker>
                        </defs>
                        
                        <path d="M 130,90 L 170,90" stroke="#1E64C8" stroke-width="2" marker-end="url(#vaccArrow)"/>
                        
                        <g transform="translate(180, 50)">
                            <rect x="0" y="0" width="140" height="80" rx="5" fill="#fff3cd" stroke="#e0a800" stroke-width="2"/>
                            <text x="70" y="18" font-size="11" fill="#e0a800" text-anchor="middle" font-weight="700">Epitope Mapping</text>
                            
                            <!-- Epitope regions -->
                            <g transform="translate(10, 28)">
                                <rect x="0" y="0" width="120" height="8" rx="2" fill="#e0e0e0"/>
                                <rect x="10" y="0" width="20" height="8" rx="2" fill="#cc0000" opacity="0.8"/>
                                <rect x="45" y="0" width="15" height="8" rx="2" fill="#cc0000" opacity="0.8"/>
                                <rect x="75" y="0" width="25" height="8" rx="2" fill="#cc0000" opacity="0.8"/>
                                
                                <text x="60" y="20" font-size="9" fill="#666" text-anchor="middle">B-cell epitopes</text>
                                
                                <rect x="0" y="28" width="120" height="8" rx="2" fill="#e0e0e0"/>
                                <rect x="20" y="28" width="30" height="8" rx="2" fill="#e0a800" opacity="0.8"/>
                                <rect x="65" y="28" width="20" height="8" rx="2" fill="#e0a800" opacity="0.8"/>
                                
                                <text x="60" y="48" font-size="9" fill="#666" text-anchor="middle">T-cell epitopes</text>
                            </g>
                        </g>
                        
                        <path d="M 325,90 L 365,90" stroke="#1E64C8" stroke-width="2" marker-end="url(#vaccArrow)"/>
                        
                        <!-- mRNA Vaccine Design -->
                        <g transform="translate(370, 40)">
                            <rect x="0" y="0" width="130" height="100" rx="5" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                            <text x="65" y="18" font-size="11" fill="#1E64C8" text-anchor="middle" font-weight="700">mRNA Design</text>
                            
                            <!-- mRNA structure -->
                            <g transform="translate(25, 30)">
                                <text x="0" y="0" font-size="9" fill="#666">5' Cap</text>
                                <circle cx="40" cy="-3" r="4" fill="#1E64C8"/>
                                
                                <path d="M 5,5 Q 15,10 25,5 T 45,5 T 65,5 T 85,5" 
                                      stroke="#2874d8" stroke-width="2" fill="none" class="rna-wave"/>
                                
                                <text x="40" y="20" font-size="9" fill="#666" text-anchor="middle">Spike gene</text>
                                
                                <text x="45" y="35" font-size="9" fill="#666">3' PolyA</text>
                                <circle cx="40" cy="38" r="4" fill="#1E64C8"/>
                            </g>
                            
                            <text x="65" y="85" font-size="9" fill="#666" text-anchor="middle">Codon optimized</text>
                        </g>
                        
                        <!-- Immune Response -->
                        <g transform="translate(180, 160)">
                            <rect x="0" y="0" width="280" height="140" rx="8" fill="#f8f9fa" stroke="#1E64C8" stroke-width="2"/>
                            <text x="140" y="20" font-size="12" fill="#1E64C8" text-anchor="middle" font-weight="700">Immune Response Prediction</text>
                            
                            <!-- B-cell response -->
                            <g transform="translate(30, 35)">
                                <circle cx="20" cy="20" r="15" fill="#ccccff" stroke="#0000cc" stroke-width="2" class="immune-pulse"/>
                                <text x="20" y="24" font-size="10" fill="#333" text-anchor="middle">B-cell</text>
                                
                                <path d="M 38,20 L 55,20" stroke="#0000cc" stroke-width="1.5" marker-end="url(#vaccArrow)"/>
                                
                                <!-- Antibodies -->
                                <g transform="translate(60, 10)">
                                    <path d="M 0,10 L 5,5 L 10,10" stroke="#0000cc" stroke-width="2" fill="none"/>
                                    <path d="M 5,5 L 5,15" stroke="#0000cc" stroke-width="2"/>
                                    
                                    <path d="M 15,10 L 20,5 L 25,10" stroke="#0000cc" stroke-width="2" fill="none"/>
                                    <path d="M 20,5 L 20,15" stroke="#0000cc" stroke-width="2"/>
                                    
                                    <text x="15" y="30" font-size="9" fill="#666" text-anchor="middle">Antibodies</text>
                                </g>
                            </g>
                            
                            <!-- T-cell response -->
                            <g transform="translate(150, 35)">
                                <circle cx="20" cy="20" r="15" fill="#ffcccc" stroke="#cc0000" stroke-width="2" class="immune-pulse" style="animation-delay: 0.5s"/>
                                <text x="20" y="24" font-size="10" fill="#333" text-anchor="middle">T-cell</text>
                                
                                <path d="M 38,20 L 55,20" stroke="#cc0000" stroke-width="1.5" marker-end="url(#vaccArrow)"/>
                                
                                <text x="80" y="24" font-size="9" fill="#666">CTL response</text>
                            </g>
                            
                            <!-- Coverage bar -->
                            <g transform="translate(30, 90)">
                                <text x="0" y="0" font-size="10" fill="#333">Population Coverage:</text>
                                <rect x="0" y="5" width="220" height="12" rx="2" fill="#e0e0e0"/>
                                <rect x="0" y="5" width="198" height="12" rx="2" fill="#1E64C8" opacity="0.7"/>
                                <text x="110" y="30" font-size="10" fill="#1E64C8" text-anchor="middle" font-weight="600">90% Coverage</text>
                            </g>
                        </g>
                        
                        <!-- Adjuvant selection -->
                        <g transform="translate(60, 320)">
                            <rect x="0" y="0" width="120" height="50" rx="5" fill="#d4edda" stroke="#1E64C8" stroke-width="1.5"/>
                            <text x="60" y="18" font-size="10" fill="#1E64C8" text-anchor="middle" font-weight="600">Adjuvant</text>
                            <text x="60" y="32" font-size="9" fill="#666" text-anchor="middle">AS01B</text>
                            <text x="60" y="44" font-size="8" fill="#666" text-anchor="middle">Enhanced response</text>
                        </g>
                    </svg>
                </div>
                
                <div class="design-principles">
                    <div class="principle-item">
                        <div class="principle-name">Epitope prediction</div>
                        <div class="principle-detail">B-cell & T-cell epitopes</div>
                    </div>
                    <div class="principle-item">
                        <div class="principle-name">Immunogenicity</div>
                        <div class="principle-detail">Immune response modeling</div>
                    </div>
                    <div class="principle-item">
                        <div class="principle-name">Coverage optimization</div>
                        <div class="principle-detail">Population HLA diversity</div>
                    </div>
                    <div class="principle-item">
                        <div class="principle-name">Adjuvant selection</div>
                        <div class="principle-detail">Enhance immune response</div>
                    </div>
                    <div class="principle-item">
                        <div class="principle-name">mRNA design</div>
                        <div class="principle-detail">Codon optimization & stability</div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 1: Epitope Prediction -->
        <div class="detailed-section">
            <div class="section-title">1. Epitope Prediction</div>
            <div class="section-content">
                <div class="section-visual">
                    <svg width="450" height="400" viewBox="0 0 450 400">
                        <!-- Antigen protein structure -->
                        <g transform="translate(50, 50)">
                            <text x="0" y="-15" font-size="14" fill="#333" font-weight="600">Pathogen Antigen</text>
                            
                            <!-- Protein backbone -->
                            <path d="M 0,30 Q 30,10 60,30 T 120,30 T 180,30 T 240,30" 
                                  stroke="#666" stroke-width="3" fill="none"/>
                            
                            <!-- B-cell epitopes (surface regions) -->
                            <g>
                                <ellipse cx="45" cy="30" rx="25" ry="18" fill="#ff6b6b" opacity="0.6" stroke="#cc0000" stroke-width="2"/>
                                <text x="45" y="65" font-size="11" fill="#cc0000" text-anchor="middle" font-weight="600">B-cell epitope</text>
                                <text x="45" y="78" font-size="9" fill="#666" text-anchor="middle">Surface exposed</text>
                            </g>
                            
                            <g>
                                <ellipse cx="165" cy="30" rx="30" ry="20" fill="#ff6b6b" opacity="0.6" stroke="#cc0000" stroke-width="2"/>
                                <text x="165" y="65" font-size="11" fill="#cc0000" text-anchor="middle" font-weight="600">B-cell epitope</text>
                                <text x="165" y="78" font-size="9" fill="#666" text-anchor="middle">Conformational</text>
                            </g>
                            
                            <!-- T-cell epitopes (internal peptides) -->
                            <g transform="translate(0, 110)">
                                <text x="120" y="0" font-size="14" fill="#333" text-anchor="middle" font-weight="600">Processed Peptides</text>
                                
                                <!-- MHC Class I pathway -->
                                <g transform="translate(20, 20)">
                                    <rect x="0" y="0" width="80" height="30" rx="3" fill="#ffd93d" opacity="0.7" stroke="#e0a800" stroke-width="2"/>
                                    <text x="40" y="18" font-size="10" fill="#333" text-anchor="middle" font-weight="600">FLKDCVMYV</text>
                                    <text x="40" y="45" font-size="10" fill="#e0a800" text-anchor="middle" font-weight="600">CD8+ T-cell epitope</text>
                                    <text x="40" y="58" font-size="8" fill="#666" text-anchor="middle">(MHC Class I)</text>
                                </g>
                                
                                <!-- MHC Class II pathway -->
                                <g transform="translate(140, 20)">
                                    <rect x="0" y="0" width="100" height="30" rx="3" fill="#ffd93d" opacity="0.7" stroke="#e0a800" stroke-width="2"/>
                                    <text x="50" y="18" font-size="10" fill="#333" text-anchor="middle" font-weight="600">AQFAPSASAFFGMS</text>
                                    <text x="50" y="45" font-size="10" fill="#e0a800" text-anchor="middle" font-weight="600">CD4+ T-cell epitope</text>
                                    <text x="50" y="58" font-size="8" fill="#666" text-anchor="middle">(MHC Class II)</text>
                                </g>
                            </g>
                        </g>
                        
                        <!-- AI Prediction Tools -->
                        <g transform="translate(50, 280)">
                            <text x="120" y="0" font-size="14" fill="#1E64C8" text-anchor="middle" font-weight="700">AI-Based Prediction Tools</text>
                            
                            <g transform="translate(0, 15)">
                                <rect x="0" y="0" width="110" height="35" rx="4" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="55" y="15" font-size="11" fill="#1E64C8" text-anchor="middle" font-weight="600">BepiPred 3.0</text>
                                <text x="55" y="28" font-size="9" fill="#666" text-anchor="middle">B-cell epitopes</text>
                            </g>
                            
                            <g transform="translate(130, 15)">
                                <rect x="0" y="0" width="110" height="35" rx="4" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="55" y="15" font-size="11" fill="#1E64C8" text-anchor="middle" font-weight="600">NetMHCpan</text>
                                <text x="55" y="28" font-size="9" fill="#666" text-anchor="middle">MHC binding</text>
                            </g>
                            
                            <g transform="translate(0, 60)">
                                <rect x="0" y="0" width="110" height="35" rx="4" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="55" y="15" font-size="11" fill="#1E64C8" text-anchor="middle" font-weight="600">IEDB Analysis</text>
                                <text x="55" y="28" font-size="9" fill="#666" text-anchor="middle">Immunogenicity</text>
                            </g>
                            
                            <g transform="translate(130, 60)">
                                <rect x="0" y="0" width="110" height="35" rx="4" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="55" y="15" font-size="11" fill="#1E64C8" text-anchor="middle" font-weight="600">AlphaFold</text>
                                <text x="55" y="28" font-size="9" fill="#666" text-anchor="middle">3D structure</text>
                            </g>
                        </g>
                    </svg>
                </div>
                
                <div class="section-text">
                    <h3>Overview</h3>
                    <p>Epitope prediction identifies specific regions on pathogen proteins that are recognized by the immune system. These epitopes serve as the primary targets for vaccine-induced immunity.</p>
                    
                    <h3>B-Cell Epitopes</h3>
                    <p>B-cell epitopes are recognized by antibodies and can be:</p>
                    <ul>
                        <li><strong>Linear epitopes:</strong> Continuous amino acid sequences (5-15 residues)</li>
                        <li><strong>Conformational epitopes:</strong> Discontinuous sequences brought together by protein folding</li>
                        <li><strong>Surface accessibility:</strong> Must be exposed on the pathogen surface</li>
                    </ul>
                    
                    <h3>T-Cell Epitopes</h3>
                    <p>T-cell epitopes are short peptide sequences presented by MHC molecules:</p>
                    <ul>
                        <li><strong>MHC Class I (8-11 amino acids):</strong> Activates CD8+ cytotoxic T-cells</li>
                        <li><strong>MHC Class II (13-25 amino acids):</strong> Activates CD4+ helper T-cells</li>
                        <li><strong>Processing requirements:</strong> Must be cleaved and loaded properly</li>
                    </ul>
                    
                    <div class="highlight-box">
                        <strong>Key Tools:</strong> Modern epitope prediction uses machine learning algorithms like BepiPred 3.0, NetMHCpan 4.1, and IEDB tools, achieving >85% accuracy in identifying immunogenic epitopes.
                    </div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 2: Immunogenicity -->
        <div class="detailed-section">
            <div class="section-title">2. Immunogenicity Prediction</div>
            <div class="section-content">
                <div class="section-visual">
                    <svg width="450" height="450" viewBox="0 0 450 450">
                        <!-- Vaccine Input -->
                        <g transform="translate(50, 30)">
                            <rect x="0" y="0" width="100" height="40" rx="5" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                            <text x="50" y="25" font-size="12" fill="#1E64C8" text-anchor="middle" font-weight="700">Vaccine Candidate</text>
                        </g>
                        
                        <!-- Arrow -->
                        <defs>
                            <marker id="arrow2" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                                <polygon points="0 0, 10 3, 0 6" fill="#1E64C8"/>
                            </marker>
                        </defs>
                        <path d="M 100,80 L 100,120" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow2)"/>
                        
                        <!-- Immune Response Components -->
                        <g transform="translate(20, 130)">
                            <rect x="0" y="0" width="360" height="250" rx="8" fill="#f8f9fa" stroke="#1E64C8" stroke-width="2"/>
                            <text x="180" y="25" font-size="14" fill="#1E64C8" text-anchor="middle" font-weight="700">Immune Response Prediction</text>
                            
                            <!-- Innate Immunity -->
                            <g transform="translate(20, 45)">
                                <rect x="0" y="0" width="150" height="80" rx="5" fill="#fff3cd" stroke="#e0a800" stroke-width="2"/>
                                <text x="75" y="18" font-size="12" fill="#333" text-anchor="middle" font-weight="600">Innate Immunity</text>
                                
                                <text x="10" y="38" font-size="10" fill="#666">• TLR activation</text>
                                <text x="10" y="52" font-size="10" fill="#666">• Inflammasome</text>
                                <text x="10" y="66" font-size="10" fill="#666">• Cytokine release</text>
                            </g>
                            
                            <!-- Adaptive Immunity -->
                            <g transform="translate(190, 45)">
                                <rect x="0" y="0" width="150" height="80" rx="5" fill="#d4edda" stroke="#28a745" stroke-width="2"/>
                                <text x="75" y="18" font-size="12" fill="#333" text-anchor="middle" font-weight="600">Adaptive Immunity</text>
                                
                                <text x="10" y="38" font-size="10" fill="#666">• B-cell activation</text>
                                <text x="10" y="52" font-size="10" fill="#666">• T-cell priming</text>
                                <text x="10" y="66" font-size="10" fill="#666">• Memory formation</text>
                            </g>
                            
                            <!-- Antibody Response -->
                            <g transform="translate(20, 140)">
                                <text x="160" y="0" font-size="12" fill="#333" text-anchor="middle" font-weight="600">Predicted Antibody Titers</text>
                                
                                <!-- Graph -->
                                <g transform="translate(30, 15)">
                                    <line x1="0" y1="60" x2="280" y2="60" stroke="#333" stroke-width="1"/>
                                    <line x1="0" y1="0" x2="0" y2="60" stroke="#333" stroke-width="1"/>
                                    
                                    <text x="-5" y="5" font-size="9" fill="#666" text-anchor="end">High</text>
                                    <text x="-5" y="65" font-size="9" fill="#666" text-anchor="end">Low</text>
                                    
                                    <!-- Response curve -->
                                    <path d="M 0,60 L 40,50 L 80,25 L 120,20 L 160,22 L 200,28 L 240,35" 
                                          stroke="#1E64C8" stroke-width="3" fill="none"/>
                                    
                                    <circle cx="80" cy="25" r="4" fill="#cc0000"/>
                                    <text x="80" y="80" font-size="8" fill="#666" text-anchor="middle">Peak (Week 4)</text>
                                    
                                    <text x="20" y="80" font-size="8" fill="#666" text-anchor="middle">Wk 1</text>
                                    <text x="120" y="80" font-size="8" fill="#666" text-anchor="middle">Wk 8</text>
                                    <text x="220" y="80" font-size="8" fill="#666" text-anchor="middle">Wk 16</text>
                                </g>
                            </g>
                        </g>
                        
                        <!-- Prediction Output -->
                        <g transform="translate(150, 395)">
                            <rect x="0" y="0" width="150" height="35" rx="5" fill="#28a745" opacity="0.2" stroke="#28a745" stroke-width="2"/>
                            <text x="75" y="15" font-size="11" fill="#28a745" text-anchor="middle" font-weight="700">Immunogenicity Score</text>
                            <text x="75" y="28" font-size="13" fill="#28a745" text-anchor="middle" font-weight="700">8.7 / 10</text>
                        </g>
                    </svg>
                </div>
                
                <div class="section-text">
                    <h3>Overview</h3>
                    <p>Immunogenicity prediction assesses how strongly a vaccine candidate will stimulate the immune system. This involves modeling both innate and adaptive immune responses.</p>
                    
                    <h3>Key Factors</h3>
                    <ul>
                        <li><strong>Antigen dose:</strong> Optimal concentration for immune activation without tolerance</li>
                        <li><strong>Route of administration:</strong> Intramuscular, subcutaneous, or intradermal delivery</li>
                        <li><strong>Adjuvant effects:</strong> Enhancement of immune recognition and response</li>
                        <li><strong>Epitope density:</strong> Number and spacing of immunogenic sites</li>
                    </ul>
                    
                    <h3>Response Modeling</h3>
                    <p>AI models predict multiple immune parameters:</p>
                    <ul>
                        <li><strong>Antibody titers:</strong> Concentration and kinetics over time</li>
                        <li><strong>T-cell response:</strong> CD4+ and CD8+ activation levels</li>
                        <li><strong>Cytokine profiles:</strong> Type and magnitude of inflammatory response</li>
                        <li><strong>Memory formation:</strong> Long-term protection durability</li>
                    </ul>
                    
                    <div class="highlight-box">
                        <strong>Clinical Validation:</strong> Immunogenicity predictions are validated against clinical trial data, with modern algorithms achieving >75% accuracy in predicting successful vaccine candidates.
                    </div>
                    
                    <h3>Safety Considerations</h3>
                    <p>Models also evaluate potential adverse reactions including autoimmunity risk, excessive inflammation, and allergic responses to ensure a favorable benefit-risk profile.</p>
                </div>
            </div>
        </div>

        <!-- Detailed Section 3: Coverage Optimization -->
        <div class="detailed-section">
            <div class="section-title">3. Population Coverage Optimization</div>
            <div class="section-content">
                <div class="section-visual">
                    <svg width="450" height="450" viewBox="0 0 450 450">
                        <!-- World map representation -->
                        <g transform="translate(50, 30)">
                            <text x="175" y="0" font-size="14" fill="#333" text-anchor="middle" font-weight="700">Global HLA Diversity</text>
                            
                            <!-- Simplified world regions -->
                            <g transform="translate(0, 20)">
                                <ellipse cx="80" cy="40" rx="60" ry="35" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="80" y="35" font-size="11" fill="#333" text-anchor="middle" font-weight="600">Europe</text>
                                <text x="80" y="48" font-size="9" fill="#666" text-anchor="middle">HLA-A*02:01 (45%)</text>
                                
                                <ellipse cx="200" cy="50" rx="70" ry="40" fill="#fff3cd" stroke="#e0a800" stroke-width="2"/>
                                <text x="200" y="45" font-size="11" fill="#333" text-anchor="middle" font-weight="600">East Asia</text>
                                <text x="200" y="58" font-size="9" fill="#666" text-anchor="middle">HLA-A*24:02 (60%)</text>
                                
                                <ellipse cx="90" cy="100" rx="55" ry="32" fill="#d4edda" stroke="#28a745" stroke-width="2"/>
                                <text x="90" y="95" font-size="11" fill="#333" text-anchor="middle" font-weight="600">Africa</text>
                                <text x="90" y="108" font-size="9" fill="#666" text-anchor="middle">HLA-B*58:01 (35%)</text>
                                
                                <ellipse cx="240" cy="100" rx="50" ry="30" fill="#ffd6d6" stroke="#cc0000" stroke-width="2"/>
                                <text x="240" y="95" font-size="11" fill="#333" text-anchor="middle" font-weight="600">Americas</text>
                                <text x="240" y="108" font-size="9" fill="#666" text-anchor="middle">HLA-B*15:01 (40%)</text>
                            </g>
                        </g>
                        
                        <!-- HLA Allele Selection -->
                        <g transform="translate(30, 180)">
                            <rect x="0" y="0" width="390" height="120" rx="6" fill="#f8f9fa" stroke="#1E64C8" stroke-width="2"/>
                            <text x="195" y="20" font-size="13" fill="#1E64C8" text-anchor="middle" font-weight="700">Multi-Epitope Vaccine Design</text>
                            
                            <!-- Epitope panel -->
                            <g transform="translate(20, 35)">
                                <text x="0" y="0" font-size="11" fill="#333" font-weight="600">Selected Epitopes:</text>
                                
                                <g transform="translate(0, 10)">
                                    <rect x="0" y="0" width="100" height="20" rx="3" fill="#ff6b6b" opacity="0.7"/>
                                    <text x="50" y="14" font-size="9" fill="#fff" text-anchor="middle" font-weight="600">FLKDCVMYV</text>
                                    <text x="110" y="14" font-size="8" fill="#666">HLA-A*02:01</text>
                                </g>
                                
                                <g transform="translate(0, 35)">
                                    <rect x="0" y="0" width="100" height="20" rx="3" fill="#4ecdc4" opacity="0.7"/>
                                    <text x="50" y="14" font-size="9" fill="#fff" text-anchor="middle" font-weight="600">RYPANSIVR</text>
                                    <text x="110" y="14" font-size="8" fill="#666">HLA-A*24:02</text>
                                </g>
                                
                                <g transform="translate(0, 60)">
                                    <rect x="0" y="0" width="100" height="20" rx="3" fill="#ffd93d" opacity="0.7"/>
                                    <text x="50" y="14" font-size="9" fill="#333" text-anchor="middle" font-weight="600">KQIYKTPPIK</text>
                                    <text x="110" y="14" font-size="8" fill="#666">HLA-B*58:01</text>
                                </g>
                                
                                <g transform="translate(200, 10)">
                                    <rect x="0" y="0" width="100" height="20" rx="3" fill="#95e1d3" opacity="0.7"/>
                                    <text x="50" y="14" font-size="9" fill="#333" text-anchor="middle" font-weight="600">DPFLGVYY</text>
                                    <text x="110" y="14" font-size="8" fill="#666">HLA-B*15:01</text>
                                </g>
                                
                                <g transform="translate(200, 35)">
                                    <rect x="0" y="0" width="100" height="20" rx="3" fill="#a8dadc" opacity="0.7"/>
                                    <text x="50" y="14" font-size="9" fill="#333" text-anchor="middle" font-weight="600">YQAGSTPCN</text>
                                    <text x="110" y="14" font-size="8" fill="#666">HLA-A*11:01</text>
                                </g>
                            </g>
                        </g>
                        
                        <!-- Coverage Analysis -->
                        <g transform="translate(30, 320)">
                            <rect x="0" y="0" width="390" height="100" rx="6" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                            <text x="195" y="20" font-size="13" fill="#1E64C8" text-anchor="middle" font-weight="700">Population Coverage Analysis</text>
                            
                            <g transform="translate(20, 35)">
                                <text x="0" y="0" font-size="11" fill="#333" font-weight="600">Global Coverage:</text>
                                <rect x="0" y="5" width="350" height="18" rx="2" fill="#e0e0e0"/>
                                <rect x="0" y="5" width="315" height="18" rx="2" fill="#28a745" opacity="0.8"/>
                                <text x="175" y="18" font-size="12" fill="#fff" text-anchor="middle" font-weight="700">90% Coverage</text>
                                
                                <text x="0" y="45" font-size="10" fill="#666">Europe: 94% | Asia: 88% | Africa: 87% | Americas: 92%</text>
                                <text x="0" y="60" font-size="9" fill="#999">Based on 12 major HLA alleles covering 95% of world population</text>
                            </g>
                        </g>
                    </svg>
                </div>
                
                <div class="section-text">
                    <h3>Overview</h3>
                    <p>Population coverage optimization ensures that a vaccine will be effective across diverse human populations, accounting for genetic variation in immune response genes (HLA alleles).</p>
                    
                    <h3>HLA Diversity Challenge</h3>
                    <p>Human Leukocyte Antigen (HLA) genes are the most polymorphic in the human genome:</p>
                    <ul>
                        <li><strong>Thousands of alleles:</strong> Over 28,000 HLA alleles identified globally</li>
                        <li><strong>Geographic variation:</strong> Different populations have distinct HLA frequency distributions</li>
                        <li><strong>Peptide binding specificity:</strong> Each HLA allele binds different peptide sequences</li>
                    </ul>
                    
                    <h3>Optimization Strategy</h3>
                    <ul>
                        <li><strong>Multi-epitope approach:</strong> Include 8-15 epitopes targeting multiple HLA alleles</li>
                        <li><strong>Frequency weighting:</strong> Prioritize alleles that are common across populations</li>
                        <li><strong>Conserved regions:</strong> Select epitopes from pathogen regions with low mutation rates</li>
                        <li><strong>Redundancy:</strong> Multiple epitopes per HLA allele for robust coverage</li>
                    </ul>
                    
                    <div class="highlight-box">
                        <strong>Coverage Targets:</strong> Modern vaccines aim for ≥90% population coverage globally. The COVID-19 mRNA vaccines achieve ~95% coverage by targeting highly conserved spike protein epitopes.
                    </div>
                    
                    <h3>Computational Tools</h3>
                    <p>Tools like IEDB Population Coverage, OptiVax, and Vaxign use algorithms to select optimal epitope combinations that maximize coverage while minimizing the number of epitopes needed.</p>
                </div>
            </div>
        </div>

        <!-- Detailed Section 4: Adjuvant Selection -->
        <div class="detailed-section">
            <div class="section-title">4. Adjuvant Selection</div>
            <div class="section-content">
                <div class="section-visual">
                    <svg width="450" height="480" viewBox="0 0 450 480">
                        <!-- Adjuvant Types -->
                        <g transform="translate(30, 20)">
                            <text x="195" y="0" font-size="14" fill="#333" text-anchor="middle" font-weight="700">Adjuvant Classification</text>
                            
                            <!-- Aluminum salts -->
                            <g transform="translate(0, 20)">
                                <rect x="0" y="0" width="180" height="70" rx="5" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                                <text x="90" y="18" font-size="12" fill="#1E64C8" text-anchor="middle" font-weight="700">Aluminum Salts</text>
                                <text x="10" y="35" font-size="10" fill="#666">• Alum (AlOH₃)</text>
                                <text x="10" y="48" font-size="10" fill="#666">• Aluminum phosphate</text>
                                <text x="10" y="61" font-size="9" fill="#999">Most widely used</text>
                            </g>
                            
                            <!-- TLR agonists -->
                            <g transform="translate(210, 20)">
                                <rect x="0" y="0" width="180" height="70" rx="5" fill="#fff3cd" stroke="#e0a800" stroke-width="2"/>
                                <text x="90" y="18" font-size="12" fill="#e0a800" text-anchor="middle" font-weight="700">TLR Agonists</text>
                                <text x="10" y="35" font-size="10" fill="#666">• CpG oligonucleotides</text>
                                <text x="10" y="48" font-size="10" fill="#666">• Monophosphoryl lipid A</text>
                                <text x="10" y="61" font-size="9" fill="#999">Strong innate activation</text>
                            </g>
                            
                            <!-- Oil emulsions -->
                            <g transform="translate(0, 105)">
                                <rect x="0" y="0" width="180" height="70" rx="5" fill="#d4edda" stroke="#28a745" stroke-width="2"/>
                                <text x="90" y="18" font-size="12" fill="#28a745" text-anchor="middle" font-weight="700">Oil Emulsions</text>
                                <text x="10" y="35" font-size="10" fill="#666">• MF59 (squalene)</text>
                                <text x="10" y="48" font-size="10" fill="#666">• AS03</text>
                                <text x="10" y="61" font-size="9" fill="#999">Enhanced uptake</text>
                            </g>
                            
                            <!-- Liposome-based -->
                            <g transform="translate(210, 105)">
                                <rect x="0" y="0" width="180" height="70" rx="5" fill="#ffd6d6" stroke="#cc0000" stroke-width="2"/>
                                <text x="90" y="18" font-size="12" fill="#cc0000" text-anchor="middle" font-weight="700">Liposome-based</text>
                                <text x="10" y="35" font-size="10" fill="#666">• AS01 (liposome + MPL)</text>
                                <text x="10" y="48" font-size="10" fill="#666">• Virosomes</text>
                                <text x="10" y="61" font-size="9" fill="#999">Targeted delivery</text>
                            </g>
                        </g>
                        
                        <!-- Mechanism of Action -->
                        <g transform="translate(30, 210)">
                            <rect x="0" y="0" width="390" height="160" rx="6" fill="#f8f9fa" stroke="#1E64C8" stroke-width="2"/>
                            <text x="195" y="22" font-size="13" fill="#1E64C8" text-anchor="middle" font-weight="700">Adjuvant Mechanisms</text>
                            
                            <g transform="translate(20, 40)">
                                <!-- Depot effect -->
                                <g>
                                    <circle cx="15" cy="10" r="8" fill="#4ecdc4" opacity="0.7"/>
                                    <text x="30" y="15" font-size="11" fill="#333" font-weight="600">Depot Formation</text>
                                    <text x="30" y="28" font-size="9" fill="#666">Sustained antigen release at injection site</text>
                                </g>
                                
                                <!-- Immune cell activation -->
                                <g transform="translate(0, 45)">
                                    <circle cx="15" cy="10" r="8" fill="#ff6b6b" opacity="0.7"/>
                                    <text x="30" y="15" font-size="11" fill="#333" font-weight="600">Immune Cell Activation</text>
                                    <text x="30" y="28" font-size="9" fill="#666">Recruitment and activation of APCs</text>
                                </g>
                                
                                <!-- Inflammation -->
                                <g transform="translate(0, 90)">
                                    <circle cx="15" cy="10" r="8" fill="#ffd93d" opacity="0.7"/>
                                    <text x="30" y="15" font-size="11" fill="#333" font-weight="600">Controlled Inflammation</text>
                                    <text x="30" y="28" font-size="9" fill="#666">Cytokine production and immune signaling</text>
                                </g>
                            </g>
                        </g>
                        
                        <!-- Selection Criteria -->
                        <g transform="translate(30, 385)">
                            <rect x="0" y="0" width="390" height="75" rx="6" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                            <text x="195" y="22" font-size="13" fill="#1E64C8" text-anchor="middle" font-weight="700">Selection Criteria</text>
                            
                            <g transform="translate(20, 35)">
                                <text x="0" y="0" font-size="10" fill="#666">✓ Antigen compatibility and stability</text>
                                <text x="0" y="15" font-size="10" fill="#666">✓ Desired immune response type (Th1/Th2 balance)</text>
                                <text x="0" y="30" font-size="10" fill="#666">✓ Safety profile and regulatory approval status</text>
                            </g>
                        </g>
                    </svg>
                </div>
                
                <div class="section-text">
                    <h3>Overview</h3>
                    <p>Adjuvants are substances added to vaccines to enhance and direct the immune response. Proper adjuvant selection is critical for vaccine efficacy and safety.</p>
                    
                    <h3>Functions of Adjuvants</h3>
                    <ul>
                        <li><strong>Immunopotentiation:</strong> Increase magnitude of immune response</li>
                        <li><strong>Dose-sparing:</strong> Achieve protection with less antigen</li>
                        <li><strong>Response shaping:</strong> Direct toward Th1 or Th2 response</li>
                        <li><strong>Duration enhancement:</strong> Prolong immune memory</li>
                    </ul>
                    
                    <h3>Major Adjuvant Classes</h3>
                    <p><strong>Aluminum-based adjuvants:</strong> Most commonly used, promote Th2 responses and antibody production. Safe track record with over 70 years of use.</p>
                    
                    <p><strong>TLR agonists:</strong> Activate pattern recognition receptors, inducing strong innate immunity and Th1 responses. Examples include CpG-ODN (TLR9) and MPL (TLR4).</p>
                    
                    <p><strong>Emulsion-based:</strong> Oil-in-water emulsions like MF59 and AS03 enhance antigen uptake and presentation, particularly effective for influenza vaccines.</p>
                    
                    <div class="highlight-box">
                        <strong>Case Study:</strong> The AS01B adjuvant used in the Shingrix vaccine combines liposomes with MPL and QS-21 saponin, achieving >90% efficacy in elderly populations by strongly activating both innate and adaptive immunity.
                    </div>
                    
                    <h3>Selection Strategy</h3>
                    <p>Adjuvant choice depends on target pathogen, patient population (age, immune status), desired response type, and regulatory considerations. AI models can predict optimal adjuvant-antigen combinations based on immunological data.</p>
                </div>
            </div>
        </div>

        <!-- Detailed Section 5: mRNA Design -->
        <div class="detailed-section">
            <div class="section-title">5. mRNA Vaccine Design</div>
            <div class="section-content">
                <div class="section-visual">
                    <svg width="450" height="500" viewBox="0 0 450 500">
                        <!-- mRNA Structure -->
                        <g transform="translate(30, 20)">
                            <text x="195" y="0" font-size="14" fill="#333" text-anchor="middle" font-weight="700">mRNA Vaccine Architecture</text>
                            
                            <rect x="0" y="15" width="390" height="180" rx="6" fill="#f8f9fa" stroke="#1E64C8" stroke-width="2"/>
                            
                            <!-- 5' Cap -->
                            <g transform="translate(20, 40)">
                                <circle cx="25" cy="15" r="12" fill="#1E64C8" opacity="0.7"/>
                                <text x="25" y="19" font-size="10" fill="#fff" text-anchor="middle" font-weight="600">m7G</text>
                                <text x="25" y="35" font-size="10" fill="#1E64C8" text-anchor="middle" font-weight="600">5' Cap</text>
                                <text x="25" y="48" font-size="8" fill="#666" text-anchor="middle">Stability</text>
                            </g>
                            
                            <!-- 5' UTR -->
                            <g transform="translate(85, 40)">
                                <rect x="0" y="0" width="60" height="30" rx="3" fill="#4ecdc4" opacity="0.6"/>
                                <text x="30" y="18" font-size="9" fill="#333" text-anchor="middle" font-weight="600">5' UTR</text>
                                <text x="30" y="48" font-size="8" fill="#666" text-anchor="middle">Translation</text>
                                <text x="30" y="58" font-size="8" fill="#666" text-anchor="middle">efficiency</text>
                            </g>
                            
                            <!-- ORF -->
                            <g transform="translate(160, 30)">
                                <rect x="0" y="0" width="120" height="50" rx="3" fill="#ff6b6b" opacity="0.6"/>
                                <text x="60" y="22" font-size="11" fill="#333" text-anchor="middle" font-weight="700">ORF</text>
                                <text x="60" y="35" font-size="9" fill="#333" text-anchor="middle">(Spike protein)</text>
                                <text x="60" y="68" font-size="8" fill="#666" text-anchor="middle">Codon optimized</text>
                                <text x="60" y="78" font-size="8" fill="#666" text-anchor="middle">GC content: 53%</text>
                            </g>
                            
                            <!-- 3' UTR -->
                            <g transform="translate(295, 40)">
                                <rect x="0" y="0" width="60" height="30" rx="3" fill="#ffd93d" opacity="0.6"/>
                                <text x="30" y="18" font-size="9" fill="#333" text-anchor="middle" font-weight="600">3' UTR</text>
                                <text x="30" y="48" font-size="8" fill="#666" text-anchor="middle">mRNA</text>
                                <text x="30" y="58" font-size="8" fill="#666" text-anchor="middle">stability</text>
                            </g>
                            
                            <!-- Poly(A) tail -->
                            <g transform="translate(300, 110)">
                                <path d="M 0,0 Q 10,8 20,0 T 40,0 T 60,0" stroke="#28a745" stroke-width="3" fill="none"/>
                                <text x="30" y="20" font-size="10" fill="#28a745" text-anchor="middle" font-weight="600">Poly(A) tail</text>
                                <text x="30" y="33" font-size="8" fill="#666" text-anchor="middle">(~100 nt)</text>
                                <text x="30" y="43" font-size="8" fill="#666" text-anchor="middle">Stability & translation</text>
                            </g>
                            
                            <!-- Modified nucleotides -->
                            <g transform="translate(20, 130)">
                                <rect x="0" y="0" width="350" height="35" rx="4" fill="#e8f2ff" stroke="#1E64C8" stroke-width="1"/>
                                <text x="175" y="18" font-size="10" fill="#1E64C8" text-anchor="middle" font-weight="600">Modified Nucleotides: N1-methylpseudouridine (m1Ψ)</text>
                                <text x="175" y="30" font-size="8" fill="#666" text-anchor="middle">Reduces innate immune activation, increases stability</text>
                            </g>
                        </g>
                        
                        <!-- Codon Optimization -->
                        <g transform="translate(30, 220)">
                            <rect x="0" y="0" width="390" height="130" rx="6" fill="#fff3cd" stroke="#e0a800" stroke-width="2"/>
                            <text x="195" y="22" font-size="13" fill="#e0a800" text-anchor="middle" font-weight="700">Codon Optimization Strategy</text>
                            
                            <g transform="translate(20, 35)">
                                <text x="0" y="0" font-size="11" fill="#333" font-weight="600">Native sequence:</text>
                                <text x="0" y="15" font-size="10" fill="#666" font-family="monospace">...TTT CCT GGT AAA...</text>
                                <text x="0" y="28" font-size="9" fill="#999">Lower GC%, suboptimal codons</text>
                                
                                <text x="0" y="50" font-size="11" fill="#333" font-weight="600">Optimized sequence:</text>
                                <text x="0" y="65" font-size="10" fill="#1E64C8" font-family="monospace">...TTC CCC GGC AAG...</text>
                                <text x="0" y="78" font-size="9" fill="#999">• Higher GC content (40-60%)</text>
                                <text x="0" y="90" font-size="9" fill="#999">• Preferred human codons</text>
                                <text x="0" y="102" font-size="9" fill="#999">• Removal of RNA instability elements</text>
                            </g>
                        </g>
                        
                        <!-- Delivery System -->
                        <g transform="translate(30, 365)">
                            <rect x="0" y="0" width="390" height="115" rx="6" fill="#d4edda" stroke="#28a745" stroke-width="2"/>
                            <text x="195" y="22" font-size="13" fill="#28a745" text-anchor="middle" font-weight="700">Lipid Nanoparticle (LNP) Delivery</text>
                            
                            <g transform="translate(80, 40)">
                                <!-- LNP structure -->
                                <circle cx="40" cy="35" r="35" fill="none" stroke="#28a745" stroke-width="2" stroke-dasharray="3,3"/>
                                <circle cx="40" cy="35" r="25" fill="#28a745" opacity="0.2"/>
                                
                                <!-- mRNA inside -->
                                <path d="M 30,35 Q 35,28 40,35 T 50,35" stroke="#1E64C8" stroke-width="2" fill="none"/>
                                <text x="40" y="55" font-size="8" fill="#666" text-anchor="middle">mRNA</text>
                                
                                <text x="40" y="-8" font-size="10" fill="#28a745" text-anchor="middle" font-weight="600">LNP Components:</text>
                            </g>
                            
                            <g transform="translate(190, 45)">
                                <text x="0" y="0" font-size="9" fill="#666">• Ionizable lipid (SM-102)</text>
                                <text x="0" y="14" font-size="9" fill="#666">• Phospholipid (DSPC)</text>
                                <text x="0" y="28" font-size="9" fill="#666">• Cholesterol</text>
                                <text x="0" y="42" font-size="9" fill="#666">• PEG-lipid (DMG-PEG)</text>
                            </g>
                        </g>
                    </svg>
                </div>
                
                <div class="section-text">
                    <h3>Overview</h3>
                    <p>mRNA vaccines represent a revolutionary platform that instructs cells to produce antigens directly. Successful design requires optimization of multiple molecular features for stability, translation efficiency, and immunogenicity.</p>
                    
                    <h3>Key Structural Elements</h3>
                    <p><strong>5' Cap structure:</strong> Modified guanosine cap (m7G or cap1) protects against degradation and enables ribosome binding for translation initiation.</p>
                    
                    <p><strong>Untranslated Regions (UTRs):</strong> The 5' UTR contains regulatory elements for translation efficiency, while the 3' UTR provides stability signals and poly(A) binding sites.</p>
                    
                    <p><strong>Open Reading Frame (ORF):</strong> Encodes the target antigen with extensive codon optimization to maximize expression while maintaining protein structure.</p>
                    
                    <h3>Codon Optimization</h3>
                    <ul>
                        <li><strong>GC content balance:</strong> Target 50-60% for optimal stability and translation</li>
                        <li><strong>Codon usage:</strong> Replace rare codons with frequently used human codons</li>
                        <li><strong>Secondary structure:</strong> Minimize hairpins and self-complementary regions</li>
                        <li><strong>Immune evasion:</strong> Remove CpG dinucleotides and uridine-rich motifs</li>
                    </ul>
                    
                    <div class="highlight-box">
                        <strong>Modified Nucleotides:</strong> COVID-19 mRNA vaccines use N1-methylpseudouridine instead of uridine. This modification reduces innate immune detection (TLR activation), increases translation efficiency by 10-fold, and improves mRNA stability.
                    </div>
                    
                    <h3>Delivery System</h3>
                    <p>Lipid nanoparticles (LNPs) encapsulate mRNA for protection and cellular delivery. The ionizable lipid component enables endosomal escape, releasing mRNA into the cytoplasm where translation occurs.</p>
                    
                    <h3>Quality Control</h3>
                    <p>Critical parameters include mRNA integrity (>80%), encapsulation efficiency (>90%), particle size (80-100 nm), and endotoxin levels. AI models predict optimal sequences and formulations before synthesis.</p>
                </div>
            </div>
        </div>

    </div>
</body>
</html>